It may not be personalised medicine, but it’s the next best thing: a guide to which drugs are likely to work best in different populations across the globe. That is the goal of the Pharmacogenetics for Every Nation Initiative (PGENI), which aims to spread the medical benefits of advances in pharmacology and genetics to the developing world.
In rich nations, doctors are thinking about tailoring drug treatment to the individual by testing people for gene variants that make certain drugs fail or cause adverse reactions. Most countries, however, cannot afford to run genetic tests on every patient, says Howard McLeod…
